Comparison Between the Bronchodilator and Cardiovascular Effects of Inhaling 0.5 mg. Riraiterol (‘Pulmadil’) and 0.2 mg. Salbutamol
- 1 January 1975
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 3 (1) , 30-35
- https://doi.org/10.1185/03007997509113642
Abstract
A comparison between the acute effects of rimiterol (0.5 mg) and salbutamol (0.2 mg.) has been made using metered dose aerosols. In this dosage it was found that the peak effect of the two drugs was the same but that the effect of rimiterol was less prolonged than that of sulbutamol. No increase in blood pressure occurred and heart rate changes were minimal after both drugs. Rimiterol is an acceptable alternative to the short-acting isoprenaline but lacks the cardiovascular effects of isoprenaline and is an alternative to salbutamol where very prolonged action is unnecessary.Keywords
This publication has 6 references indexed in Scilit:
- Response to Rimiterol and Salbutamol Aerosols Administered by Intermittent Positive-pressure VentilationBMJ, 1974
- Clinical assessment of bronchodilator drugs delivered by aerosolThorax, 1973
- The use of histamine induced bronchoconstriction as a method for investigating bronchodilator drugsRespiratory Medicine, 1972
- Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized catBritish Journal of Pharmacology, 1972
- SINGLE SHOTS v. DIVIDED DOSES OF A BRONCHODILATOR IN THE RELIEF OF REVERSIBLE AIRWAYS OBSTRUCTIONThe Lancet, 1972
- Selectivity of bronchodilator action of salbutamol in asthmatic patientsRespiratory Medicine, 1971